近日,远大医药(0512.HK)发布公告称,其位于成都温江的核药全球研发及生产基地已获得国家生态环境部颁发的甲级《辐射安全许可证》,并将于2025年6月正式投入运营。根据公告,远大医药成都温江的核药全球研发及生产基地定位全球创新核药产业化高地,是全球首个“零辐射”智能核药工厂,全流程辐射监测系统达到核电级安全标准。该基地占地面积50亩,一期用地25亩,建设总面积超2.6万平方米,总规划投资拟超30...
Source Link近日,远大医药(0512.HK)发布公告称,其位于成都温江的核药全球研发及生产基地已获得国家生态环境部颁发的甲级《辐射安全许可证》,并将于2025年6月正式投入运营。根据公告,远大医药成都温江的核药全球研发及生产基地定位全球创新核药产业化高地,是全球首个“零辐射”智能核药工厂,全流程辐射监测系统达到核电级安全标准。该基地占地面积50亩,一期用地25亩,建设总面积超2.6万平方米,总规划投资拟超30...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.